Cutting-Edge GPC3 Therapies for Advanced Liver Cancer
The Anti-GPC3 Targeted Therapies Market is rapidly becoming a central focus in oncology, emphasizing precision treatments that target glypican-3 (GPC3)—a surface protein overexpressed in hepatocellular carcinoma (HCC) and other tumors.



